Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated:  12/31/1969
Medical University
6093
mi
from 91732
Vienna,
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated: 12/31/1969
Medical University
6093
mi
from 91732
Vienna,
Click here to add this to my saved trials
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography (NORDICA Study)
Status: Enrolling
Updated:  12/31/1969
UNC Center for Heart & Vascular Care
2194
mi
from 91732
Chapel Hill, NC
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography
Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography (NORDICA Study)
Status: Enrolling
Updated: 12/31/1969
UNC Center for Heart & Vascular Care
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Women's Care of Nashua
2556
mi
from 91732
Nashua, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Women's Care of Nashua
2556
mi
from 91732
Nashua, NH
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Dartmouth-Hitchcock Nashua
2556
mi
from 91732
Nashua, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Dartmouth-Hitchcock Nashua
2556
mi
from 91732
Nashua, NH
Click here to add this to my saved trials
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated:  12/31/1969
Southern New Hampshire Medical Center
2556
mi
from 91732
Nashua, NH
Vacuum Assisted Closure for Cesarean Section
Incisional VAC at Cesarean Section for Prevention of Post Operative Wound Complications in the Obese
Status: Enrolling
Updated: 12/31/1969
Southern New Hampshire Medical Center
2556
mi
from 91732
Nashua, NH
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Center
4
mi
from 91732
Duarte, CA
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Center
4
mi
from 91732
Duarte, CA
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
University of Minnesota, Masonic Cancer Center
1511
mi
from 91732
Minneapolis, MN
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
University of Minnesota, Masonic Cancer Center
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
1959
mi
from 91732
Columbus, OH
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
962
mi
from 91732
Seattle, WA
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
962
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital-Winship Cancer Institute
1919
mi
from 91732
Atlanta, GA
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital-Winship Cancer Institute
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
25
mi
from 91732
Los Angeles, CA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Stanford University
329
mi
from 91732
Palo Alto, CA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Stanford University
329
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Emory University
1919
mi
from 91732
Atlanta, GA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Emory University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Indiana University
1791
mi
from 91732
Indianapolis, IN
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Indiana University
1791
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Iowa
1527
mi
from 91732
Iowa City, IA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Iowa
1527
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Wayne State University
1965
mi
from 91732
Detroit, MI
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Wayne State University
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
1341
mi
from 91732
Kansas City, MO
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Rochester
2244
mi
from 91732
Rochester, NY
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Rochester
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
RTI International
2204
mi
from 91732
Durham, NC
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
RTI International
2204
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Duke University
2203
mi
from 91732
Durham, NC
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Medical Center
1880
mi
from 91732
Cincinnati, OH
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
2036
mi
from 91732
Cleveland, OH
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
The Research Institute at Nationwide Children's Hospital
1962
mi
from 91732
Columbus, OH
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
The Research Institute at Nationwide Children's Hospital
1962
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
2562
mi
from 91732
Providence, RI
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
1221
mi
from 91732
Dallas, TX
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Utah
572
mi
from 91732
Salt Lake City, UT
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Evaluation of Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Evaluation of Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Using Biomarkers to Optimize Antibiotic Strategies in Sepsis
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network - Randomized Control Trial
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania - Medical Intensive Care Unit
2375
mi
from 91732
Philadelphia, PA
Using Biomarkers to Optimize Antibiotic Strategies in Sepsis
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network - Randomized Control Trial
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania - Medical Intensive Care Unit
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Status: Enrolling
Updated:  12/31/1969
Indiana University d/b/a/ Methodist Research Institute
1792
mi
from 91732
Indianapolis, IN
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Status: Enrolling
Updated: 12/31/1969
Indiana University d/b/a/ Methodist Research Institute
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department
Ketamine Infusion for Acute Sickle Cell crisiS in the Emergency Department
Status: Enrolling
Updated:  12/31/1969
Brooklyn Hospital Center
2433
mi
from 91732
Brooklyn, NY
Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department
Ketamine Infusion for Acute Sickle Cell crisiS in the Emergency Department
Status: Enrolling
Updated: 12/31/1969
Brooklyn Hospital Center
2433
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Remote Interrogation in Rural Emergency Departments
Remote Interrogation of Implantable Cardiac Devices in Rural Emergency Departments
Status: Enrolling
Updated:  12/31/1969
New Mexico Heart Institute
649
mi
from 91732
Albuquerque, NM
Remote Interrogation in Rural Emergency Departments
Remote Interrogation of Implantable Cardiac Devices in Rural Emergency Departments
Status: Enrolling
Updated: 12/31/1969
New Mexico Heart Institute
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
VR High Tech Pain Control Burn Wound Care
High Technology Pain Control During Burn Wound Care
Status: Enrolling
Updated:  12/31/1969
University of Washington; Harborview Medical Center
961
mi
from 91732
Seattle, WA
VR High Tech Pain Control Burn Wound Care
High Technology Pain Control During Burn Wound Care
Status: Enrolling
Updated: 12/31/1969
University of Washington; Harborview Medical Center
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Peri-operative NIRS Monitoring In Infants
Cerebral Near-infrared Spectroscopy Monitoring in Infants During the Peri-operative Period: a Prospective Observational Cohort Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Peri-operative NIRS Monitoring In Infants
Cerebral Near-infrared Spectroscopy Monitoring in Infants During the Peri-operative Period: a Prospective Observational Cohort Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
AKDHC Medical Research Services, LLC
343
mi
from 91732
Phoenix, AZ
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
AKDHC Medical Research Services, LLC
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
AKDHC Medical Research Services, LLc
429
mi
from 91732
Tucson, AZ
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
AKDHC Medical Research Services, LLc
429
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
VA Loma Linda Healthcare System
43
mi
from 91732
Loma Linda, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
VA Loma Linda Healthcare System
43
mi
from 91732
Loma Linda, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Long Beach
21
mi
from 91732
Long Beach, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Long Beach
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente
103
mi
from 91732
San Diego, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente
103
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
California Institute of Renal Research
100
mi
from 91732
San Diego, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
California Institute of Renal Research
100
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Northern California
356
mi
from 91732
San Francisco, CA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Northern California
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Chicago
1730
mi
from 91732
Chicago, IL
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Lutheran Hospital Network of Indiana
1852
mi
from 91732
Fort Wayne, IN
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Lutheran Hospital Network of Indiana
1852
mi
from 91732
Fort Wayne, IN
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
1528
mi
from 91732
Iowa City, IA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Multicenter, Double Blind, Placebo Controlled Study of Vonapanitase (PRT- 201) Administered Immediately After Radiocephalic Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials